These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8689950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.
    Dolan ME, Roy SK, Fasanmade AA, Paras PR, Schilsky RL, Ratain MJ.
    J Clin Oncol; 1998 May; 16(5):1803-10. PubMed ID: 9586894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
    Long L, Berg SL, Roy SK, McCully CL, Song-Yoo HW, Moschel RC, Balis FM, Dolan ME.
    Clin Cancer Res; 2000 Sep; 6(9):3662-9. PubMed ID: 10999759
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of oral O6-benzylguanine and evidence of interaction with oral ketoconazole in the rat.
    Ewesuedo RB, Dolan ME.
    Cancer Chemother Pharmacol; 2000 Sep; 46(2):150-5. PubMed ID: 10972485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
    Roy SK, Moschel RC, Dolan ME.
    Drug Metab Dispos; 1996 Nov; 24(11):1205-11. PubMed ID: 8937854
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley rats.
    Kokkinakis DM, Moschel RC, Pegg AE, Dolan ME, Schold SC.
    Chem Res Toxicol; 1994 Nov; 7(6):762-9. PubMed ID: 7696530
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ, Nagasubramanian R, Delaney SM, Cherian MM, Lin S, Kogan SC, Dolan ME.
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [Abstract] [Full Text] [Related]

  • 19. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
    Mitchell RB, Moschel RC, Dolan ME.
    Cancer Res; 1992 Mar 01; 52(5):1171-5. PubMed ID: 1737376
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of O(6)-benzylguanine in pediatric patients with central nervous system tumors: a pediatric oncology group study.
    Neville K, Blaney S, Bernstein M, Thompson P, Adams D, Aleksic A, Berg S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5072-5. PubMed ID: 15297409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.